Ignite Creation Date:
2024-05-06 @ 7:39 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06085755
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-14
First Post:
2023-09-10
Brief Title:
Trastuzumab DeruxtecanT-DXd and Afatinib Combination in HER2-low Advanced Gastric Cancer
Sponsor:
Jeeyun Lee
Organization:
Samsung Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-10
First Submit QC Date:
October 16 2023
Study First Post Date:
2023-10-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-23
Last Update Post Date:
2024-05-14
Last Update Post Date Type:
ACTUAL